<30
Total Human Subjects
in all published BPC-157 trials combined
0
Placebo-Controlled RCTs
as of 2026 — no gold-standard trials exist
100+
Preclinical Studies
216 PubMed-indexed articles total
$25-50
Monthly Cost
at community protocol from research-peptide vendor
The Evidence Question
PubMed · QuantifiedThe most honest single visual on this page. BPC-157 has been studied for 30+ years — but almost entirely in animals. Human evidence is dramatically thin compared to community enthusiasm.
What Animal Models Actually Show
PubMed · Animal StudiesSpecific quantified findings from peer-reviewed animal models. Cannot be extrapolated directly to humans — but consistently replicated where tested.
Tendon & Ligament Healing
~2×
Faster biomechanical recovery vs control in 14-21 day rat models. Achilles transection, ligament tears, muscle injuries all accelerated.
Wound Closure
2-3×
Faster re-epithelialization in skin incision, excision, diabetic ulcer, alkali burn rat models
GI Ulcer Recovery
7-Day
Rat gastric ulcer models recover within a week vs much longer in controls. BPC-157 originated from gastric juice — strongest mechanistic match.
Spinal Cord Injury
Motor Recovery
Functional motor recovery observed in rat spinal cord injury models — preclinical only, no human data
Published Human Trials
PubMed · Clinical (Limited)Every BPC-157 human trial ever published, with sample size and outcome. Note: zero placebo-controlled RCTs exist.
| # | Study | Type | n | Outcome |
|---|---|---|---|---|
| 1 |
Intra-Articular BPC-157 for Knee Pain
|
Pilot | 16 | 14/16 (87.5%) pain relief |
| 2 |
BPC-157 for Interstitial Cystitis
|
Pilot | small | Symptom improvement |
| 3 |
IBD Trials (Croatia, early 2000s)
|
Small RCT | small | Safe + effective for IBD |
| 4 |
Orthopaedic Sports-Med Systematic Review
|
Sys. Review | — | 1 clinical of 544 screened |
Reality check: Total human subjects in published BPC-157 trials < ~30. Zero placebo-controlled RCTs exist. The 2025 HSS systematic review screened 544 papers in orthopedics — only 1 was a clinical study; the other 35 included papers were animal models.
Cost vs Alternative Healing Modalities
Market Data · US 2026If you have a tendon, ligament, or joint injury — what are the actual options and what do they cost? Honest comparison of evidence strength, typical cost, and timeline.
Most Evidence
Physical Therapy
$900-4000
total course, cash
6-18 sessions over 4-12 weeks
$100-200 / session
$100-200 / session
Cortisone Injection
$50-250
per shot, cash
1-3 shots / year
Fast pain relief, evidence-backed
Fast pain relief, evidence-backed
PRP Injection
$500-2500
per shot, rarely covered
2-4 sessions typical
$2,000-6,000 total course
$2,000-6,000 total course
Research Only
BPC-157 Protocol
$25-50
per month, gray-market vendor
4-8 weeks typical cycle
Not FDA approved · not prescribable
Not FDA approved · not prescribable
Last Resort
Surgery + PT Recovery
$5K-25K+
all-in, varies wildly
20-40 PT sessions after
ACL: 30-40 · rotator cuff: 24-36
ACL: 30-40 · rotator cuff: 24-36
Typical Community Protocol
T4 · Clinic / Community SourcesThese dosing patterns come from clinic blogs, peptide vendors, and public protocols (including Andrew Huberman's reported regimen). No FDA-approved dose exists. Dose does not scale meaningfully by body weight in reported protocols — a 180-lb adult uses the same dose as a 140-lb adult.
Standard
250 mcg 2× / day
500 mcg/day total · subcutaneous near injury · 4-8 week cycle
Huberman Variant
300-500 mcg, 2-3×/week
8 weeks on · 8-10 weeks off · subcutaneous
Chronic Issues
Same dose, extended
8-12 weeks for chronic conditions
Critical Caveat
Research use only
Sold as research peptide, not for human use. No dose-response study published. Talk to a peptide-literate physician.
Regulatory Position
T1 · Official AgenciesFDA (USA)
Category 2 — Significant Safety Risk
Added to Category 2 bulks list, December 2023. Compounding pharmacies can no longer produce BPC-157. Cited concerns: immune reactions, peptide impurities, no comprehensive human safety data.
USADA / Anti-Doping
Prohibited for Athletes
Experimental peptide flagged as creating risk for athletes. WADA had it on banned list in 2022; USADA prohibition continues regardless of current WADA status.
DoD OPSS
Unapproved Drug — Do Not Use
U.S. Department of Defense Operation Supplement Safety lists BPC-157 as a prohibited peptide and unapproved drug. Service members directed to avoid all forms.
Community / User Reports
Anecdotal · Not Evidence
This section is anecdotal. Personal accounts and clinic-reported timelines. Not controlled, not blinded. Cannot replace clinical evidence — included for context on what the community claims.
Joe Rogan
2 Weeks
Elbow tendonitis reportedly resolved after BPC-157 use (podcast statements)
Andrew Huberman
2 Injections
L5 compression pain reportedly resolved after two injections (Huberman Lab)
Clinic-Reported Timelines
2-12 Weeks
Tendons 2-3 weeks, knees up to 2 months (T4 clinic blogs — commercial interest disclosed)
New to BPC-157? Start Here.
Imagine a small piece of a protein your own stomach already makes every day — one researchers discovered in the 1990s, isolated, and have been quietly studying for thirty years. That's BPC-157. The short version: animal studies are remarkable, human studies are tiny, and an entire community of athletes and biohackers is already using it while the science catches up. Here's the honest tour.
What it is
A 15-amino-acid fragment of a protein found naturally in human gastric juice. The name stands for "Body Protection Compound." It's a peptide — not a steroid, not a drug in the traditional sense, just a small piece of something your body already produces.
What it does
In animal studies it accelerates healing of tendons, ligaments, muscle, gut lining, and even nerve tissue. The mechanism is real and replicated: it boosts blood-vessel formation (angiogenesis), protects cells from stress, and activates growth-factor pathways. Animals heal in days what controls heal in weeks.
How people use it
Community protocol: 250 mcg twice a day (500 mcg total), injected subcutaneously near the injury, in 4–8 week cycles. Most users target a specific issue — tendonitis, a stubborn knee, gut inflammation — rather than taking it continuously. Cost runs $25–50 a month at gray-market vendors.
Is it legal?
It's in a gray zone. Not FDA-approved, can't be legally prescribed in the U.S., banned by USADA for competitive athletes, and the Department of Defense warns service members against it. Sold openly online as a "research peptide" labeled not for human use — with a wink everyone understands.
Should you try it?
That's a personal call — this page won't make it for you. What we can say: the community is running 5–10 years ahead of formal clinical evidence. If you do try it, source from a reputable research-peptide vendor, talk to a peptide-literate physician, start low, and accept that you are the experiment.
Key Takeaways
- Mechanism is real and replicated across animal models — cytoprotection, angiogenesis, NO-system, growth factors
- Published human trials total fewer than ~30 subjects — no placebo-controlled RCTs exist
- FDA, USADA, and DoD all flag safety risks: immune reactions, peptide impurities, no long-term human data
- Cost is genuinely low at the gray-market vendor level ($25–50/month) — well below cortisone, PRP, or surgery
- If you try it: research-only sourcing, talk to a peptide-literate physician, understand you are the experiment